PMID: 15222608Jun 30, 2004Paper

Nosocomial pneumonia

La Revue du praticien
Jean-Yves Fagon

Abstract

Nosocomial pneumonia complicates the course of a large number of hospitalized patients, associated with a higher risk of death, prolonged length of stay and over-costs. Rates of pneumonia are considerably higher in the ICU, in the post-operative period, particularly in patients treated with mechanical ventilation. Microorganisms responsible for nosocomial pneumonia are frequently multiresistant, particularly in case of late-onset pneumonia and in patients receiving prior antimicrobial therapy. Management of patients suspected of having nosocomial pneumonia aims to identify patients with true lung infection and not only colonization of the lower respiratory tract, to identify responsible pathogen(s) and to optimize the choice of antimicrobial therapy. To do that, bronchoscopic techniques with the use of bronchoalveolar lavage or protected specimen brush have the best sensitivity and specificity. Appropriate antimicrobial treatment must be initiated without delay. The potential interest of combination therapy, nebulized antibiotics needs to be clearly demonstrated by further investigations; similarly the optimal duration of treatment ensuring efficacy and avoiding the emergence and development of infections due to multiresistant ...Continue Reading

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Current Opinion in Pulmonary Medicine
J Chastre, J L Trouillet
American Journal of Respiratory and Critical Care Medicine
J Chastre, Jean-Yves Fagon
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
J ChastreJ L Trouillet
© 2022 Meta ULC. All rights reserved